Form 4: Teva Pharmaceutical Industries Executive VP Eric Drape Reports Share Transactions
SEC Form 4
Executive VP of Global Operations at Teva Pharmaceutical Industries, Eric Drape, reports the vesting and disposal of restricted share units, resulting in the acquisition of ordinary shares.
Summary
- Eric Drape, Executive VP of Global Operations at Teva Pharmaceutical Industries, filed a Form 4 detailing changes in beneficial ownership.
- On March 3, 2024, 24,900 restricted share units vested, resulting in the acquisition of 24,900 ordinary shares and the disposal of 44,416 ordinary shares.
- On March 4, 2024, 33,512 restricted share units vested, resulting in the acquisition of 33,512 ordinary shares and the disposal of 77,928 ordinary shares.
- Following these transactions, Drape directly owns 74,701 ordinary shares and 67,024 restricted share units.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing executive stock transactions, indicating a neutral sentiment.
Industry Context
This filing is a routine disclosure related to executive compensation and equity ownership, common in publicly traded companies.
Stakeholder Impact
- The vesting of restricted share units impacts the executive's ownership stake in the company.
- The transactions may have a minor impact on the overall shareholding structure.
Key Dates
| Date | Description |
|---|---|
| 03/03/2023 | Restricted share units were granted, with 24,900 vesting on each of March 3, 2024, March 3, 2025 and March 3, 2026, and 24,901 vesting on March 3, 2027. |
| 03/04/2022 | Restricted share units were granted, with 33,512 vested on March 4, 2023 and March 4, 2024, and 33,512 vesting on each of March 4, 2025 and March 4, 2026. |
| 03/03/2024 | 24,900 restricted share units vested, resulting in the acquisition of 24,900 ordinary shares. |
| 03/04/2024 | 33,512 restricted share units vested, resulting in the acquisition of 33,512 ordinary shares. |
| 03/05/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.